. Author manuscript; available in PMC: 2020 Apr 15.

Published in final edited form as: Clin Cancer Res. 2019 Aug 30;25(20):6098–6106. doi: 10.1158/1078-0432.CCR-19-0818

Table 1: Description of angiogenic factors and cytokines measured.

Variations in patient number were due to sample availability, and unreadable samples including those that were insufficient or outside the assay detection range.

Angiogenic factor/cytokine	Alternative names	Selected citations	Patient samples measured (N)
Angiogenic factor/cytokine	Alternative names	Selected citations	Baseline	Week 4	Week 6
VEGF		(5,6,8,10)	363	192	168
PlGF	PGF	(6,10)	363	192	168
sFlt1	sVEGFR-1	(40)	363	192	167
sVEGFR-2	KDR	(5,6,8)	370	194	171
Ang2	ANGPT2	(13,14)	361	192	168
bFGF	FGF-2	(6,8)	354	191	161
HGF		(6–8)	370	194	171
IFNγ		(8,33)	328	167	156
IL8	CXCL8	(6–8)	349	182	167
CXCL9	MIG	(6,15)	370	194	170
CXCL10	IP-10	(6,12,15)	370	194	171
CXCL11	ITAC, IP-9	(12,15,33)	370	194	170